Home

Francis M Cuss

CIK 1490216 · EVP & CSO · last filed 2025-12-05

Francis M Cuss is an EVP & CSO who has filed 42 SEC Form 4 insider transactions across 3 companies since 2011. The most recent filing, for MURAV, was dated Dec 5, 2025. Across all open-market trades the lifetime net is −$19.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $23.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$23.17M

Companies

3

Total Filings

42

Lifetime Open-Market Net

-$18.97M

Filer Profile

Reported Address
BRISTOL-MYERS SQUIBB COMPANY
ROUTE 206 & PROVINCE LINE ROAD
PRINCETON, NJ 08543
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MURAV Director — — — $0 5 2025-12-05
Rubius Therapeutics, Inc. (RUBY) Delisted Director 10,000 $0.08 $830 $230.0K 6 2022-05-13
BMY EVP & CSO 346,769 $66.82 $23.17M -$19.20M 31 2017-03-14

Recent Filings

42 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-12-05 MURAV Disp (D) — $0 EDGAR
2025-06-13 MURAV Grant (A) — $0 EDGAR
2024-06-05 MURAV Grant (A) — $0 EDGAR
2024-06-03 MURAV Grant (A) — $0 EDGAR
2023-12-18 MURAV Grant (A) — $0 EDGAR
2022-05-13 Rubius Therapeutics, Inc. (RUBY) Delisted Grant (A) — $0 EDGAR
2021-05-13 Rubius Therapeutics, Inc. (RUBY) Delisted Grant (A) — $0 EDGAR
2020-05-26 Rubius Therapeutics, Inc. (RUBY) Delisted Grant (A) — $0 EDGAR
2019-05-28 Rubius Therapeutics, Inc. (RUBY) Delisted Grant (A) — $0 EDGAR
2018-07-23 Rubius Therapeutics, Inc. (RUBY) Delisted Buy (P) +10,000 $230.0K EDGAR
Showing 1–10 of 42
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.